Despite emerging evidence of NKX6.3’s involvement in GC progression [14–16], the precise molecular mechanisms by which it exerts its tumor-suppressive effects - especially regarding cell cycle dynamics - have yet to be thoroughly investigated. The gene discussed is NKX6-3; the disease is neoplasm.